OSCNX
Price
$24.77
Change
-$0.10 (-0.40%)
Updated
Jul 31 closing price
Net Assets
2.58B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

OSCNX vs VSCIX

OSCNX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
OSCNX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OSCNX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. OSCNX (2.58B). VSCIX pays higher dividends than OSCNX: VSCIX (1.23) vs OSCNX (0.27). OSCNX was incepted earlier than VSCIX: OSCNX (13 years) vs VSCIX (29 years). OSCNX (1.30) is less costly to investors than VSCIX (0.03). OSCNX is a more actively managed with annual turnover of: 53.00 vs. VSCIX (17.00). OSCNX has a lower initial minimum investment than VSCIX: OSCNX (1000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. OSCNX (15.89). VSCIX return over 5 years is better than : 35.13 vs. OSCNX (18.76).
OSCNXVSCIXOSCNX / VSCIX
Total Expense Ratio1.300.034,333%
Annual Report Gross Expense Ratio1.300.034,333%
Fund Existence13 years29 years-
Gain YTD16.34614.591112%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.58B189B1%
Annual Yield % from dividends0.271.2322%
Returns for 1 year15.8922.5870%
Returns for 3 years27.4143.4463%
Returns for 5 years18.7635.1353%
Returns for 10 years98.22156.0763%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C